ClinicalTrials.gg
Drug

Ocrelizumab clinical trials

Also written Ocrevus and RO4964913.

studies test it
56
open now
6
in phase 3
30
first study started
2004

How each study uses ocrelizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ocrelizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Mar 2017 · OCREVUS · BLA 761053 (FDA, Drugs@FDA)
European Union
8 Jan 2018 · Ocrevus · EMEA/H/C/004043 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ocrelizumab
48
RO4964913; Ocrevus
2

Brand

Ocrevus
12

Development codes

RO4964913
11
CYB704
1
RPH-035
1

Studies by the year they started

56 studies that test it; most in 2022 (7)

Studies that test ocrelizumab, by start year
YearStudies
20041
20052
20061
20073
20084
20091
20113
20163
20172
20184
20196
20206
20213
20227
20233
20242
20254
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
10
Phase 3
30
Phase 4
15

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 41 · Other 15

Hoffmann-La Roche (23) · Genentech, Inc. (13) · University of California, San Francisco (2) · Johns Hopkins University (2) · Sandoz (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · R-Pharm (1)

Often tested with

Tested in the same studies.

Siponimod (1) · Methotrexate (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 7 phase 3 studies under way

Ocrelizumab is the comparator. A study of two new drugs counts under both.

  • 2Rituximab · Rigshospitalet, Denmark, Haukeland University Hospital
  • 1Fenebrutinib · Hoffmann-La Roche
  • 1Cyclophosphamide · Haukeland University Hospital · next primary completion Nov 2026
  • 1Antilymphocyte Serum · Haukeland University Hospital · next primary completion Nov 2026
  • 1Remibrutinib · Novartis Pharmaceuticals · next primary completion Jul 2029
Reaching primary completion within a year · 5, 2 in phase 3

Studies that test ocrelizumab, phase 3 first.

Studies

Open first, then newest update. How each study uses ocrelizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 56

See all 56 studies that test ocrelizumab →

Given beside what is tested · 4 — ocrelizumab is usual care or a partner of the new treatment
As the comparator · 10 — what is tested is compared with ocrelizumab

Codes

What other systems call ocrelizumab · ClinicalTrials.gg INT005359

  • MeSH (NLM) C533411ocrelizumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) A10SJL62JYOCRELIZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1876366Confirmed FDA, Wikidata
  • Wikidata Q2013780ocrelizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66250OcrelizumabOne source FDA
  • DrugBank DB11988One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.